Tradestie Institutional Equity Comparison Engine
SABA vs HSTM โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
HSTM Overall Edge
HSTM Captures Institutional Edge (4โ0 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to HealthStream Inc (HSTM) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, SABA trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus HSTM at 28.6x Forward P/E and 7.8% operating margin (+8.9% YoY). In options structure, SABA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against HSTM sits in UNCLASSIFIED (50th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
HSTM
SABA N/M vs HSTM 28.6x Fwd P/E
Growth & Margin Winner
HSTM
Op Margin N/A vs 7.8% ยท YoY N/A vs +8.9%
Momentum & Technical Winner
HSTM
1Y -16.0% vs +6.8% ยท 52W Pos 4% vs 42%
Options & Structure Winner
HSTM
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (50th %ile IV)
SABA
NYSE
Saba Capital Income & Opportunities Fund II
Institutional Equity
$7.33
-0.27% 1D
Market Cap
$251.8M
1M Return
-3.68%
1Y Return
-16.04%
Forward P/E
N/M
Unified AI Score
44.2 / 100
HOLD
Tech 38.0
Fund 55.0
Flow 50.0
Mom 55.0
HSTM
NASDAQ
HealthStream Inc
Services-Computer Programming, Data Processing, Etc.
$26.29
+0.19% 1D
Market Cap
$802.8M
1M Return
-24.0%
1Y Return
+6.78%
Forward P/E
28.6x
Unified AI Score
50.5 / 100
HOLD
Tech 45.0
Fund 50.0
Flow 50.0
Mom 55.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
SABA -16.04%
HSTM +6.78%
Spread: +22.82 pp (HSTM Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
SABA TTM Op. Margin: N/A
HSTM TTM Op. Margin: 7.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SABA vs HSTM. Trailing 12-month operating profitability (SABA N/A vs HSTM 7.8%) and valuation multiples (SABA N/M vs HSTM 28.6x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | SABA | HSTM | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $251.8M | $802.8M | Larger Scale | HSTM |
| Trailing P/E Ratio Valuation | N/M | 37.5x | Lower Multiple | HSTM |
| Forward P/E Ratio Valuation | N/M | 28.6x | Lower Multiple | HSTM |
| Revenue Growth (YoY) Growth | N/A | +8.9% | Higher Growth | HSTM |
| Operating Margin (TTM) Profitability | N/A | 7.8% | Higher Margin | HSTM |
| Net Profit Margin Profitability | N/A | 6.2% | Higher Margin | HSTM |
| Return on Equity (ROE) Capital Efficiency | N/A | 5.5% | Higher ROE | HSTM |
| 52-Week Range Position Momentum | 4% ($7โ$9) | 42% ($20โ$36) | Stronger Trend | HSTM |
| Beta / 30D Volatility Risk Regime | 0.37ฮฒ ยท 13% Vol | 0.38ฮฒ ยท 44% Vol | Lower Realized Risk | SABA |
| Unified Institutional Score Composite Signal | 44.2 / 100 (HOLD) | 50.5 / 100 (HOLD) | Higher Composite | HSTM |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full SABA vs HSTM Buy Guide
SABA
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
HSTM
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
50th %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither SABA nor HSTM registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.